Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109684559 | 10968455 | 9 | F | 201401 | 20160920 | 20150330 | 20160922 | EXP | PHHY2015BR035425 | NOVARTIS | 43.84 | YR | F | Y | 63.00000 | KG | 20160922 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109684559 | 10968455 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 10 MG, QMO, EVERY 28 DAYS | U | 21008 | 10 | MG | VIAL | /month | |||||
| 109684559 | 10968455 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO, EVERY 28 DAYS | U | 21008 | 20 | MG | VIAL | /month | |||||
| 109684559 | 10968455 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EACH 45 DAYS | U | 21008 | 20 | MG | VIAL | ||||||
| 109684559 | 10968455 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO, EVERY 28 DAYS | U | SA471 | 21008 | 20 | MG | VIAL | /month | ||||
| 109684559 | 10968455 | 5 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EVERY 40 DAYS | U | SC499 | 21008 | 20 | MG | VIAL | |||||
| 109684559 | 10968455 | 6 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | U | SC499 | 21008 | 20 | MG | VIAL | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109684559 | 10968455 | 1 | Acromegaly |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109684559 | 10968455 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109684559 | 10968455 | Abdominal pain | |
| 109684559 | 10968455 | Anxiety | |
| 109684559 | 10968455 | Blood growth hormone decreased | |
| 109684559 | 10968455 | Blood growth hormone increased | |
| 109684559 | 10968455 | Cardiomegaly | |
| 109684559 | 10968455 | Chest pain | |
| 109684559 | 10968455 | Colitis | |
| 109684559 | 10968455 | Diarrhoea | |
| 109684559 | 10968455 | Faeces soft | |
| 109684559 | 10968455 | Food allergy | |
| 109684559 | 10968455 | Headache | |
| 109684559 | 10968455 | Hyperthyroidism | |
| 109684559 | 10968455 | Inappropriate schedule of drug administration | |
| 109684559 | 10968455 | Influenza | |
| 109684559 | 10968455 | Insulin-like growth factor increased | |
| 109684559 | 10968455 | Liver disorder | |
| 109684559 | 10968455 | Neoplasm progression | |
| 109684559 | 10968455 | Nervousness | |
| 109684559 | 10968455 | Peripheral swelling | |
| 109684559 | 10968455 | Pharyngitis | |
| 109684559 | 10968455 | Pyrexia | |
| 109684559 | 10968455 | Vomiting | |
| 109684559 | 10968455 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109684559 | 10968455 | 1 | 2003 | 0 | ||
| 109684559 | 10968455 | 2 | 201409 | 201412 | 0 | |
| 109684559 | 10968455 | 3 | 201412 | 0 | ||
| 109684559 | 10968455 | 4 | 20150410 | 0 | ||
| 109684559 | 10968455 | 5 | 201602 | 0 |